Søgeresultater - B Charpentier
- Showing 1 - 11 results of 11
-
1
-
2
-
3
OUTCOMES AS A FUNCTION OF DONOR:RECIPIENT CHARACTERISTICS FROM A PHASE III STUDY OF BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANTATION (BENEFIT) af F. Vincenti, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Lionel Rostaing, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Christian P. Larsen
Udgivet 2010Artigo -
4
BELATACEPT VS CYCLOSPORINE IN KIDNEY TRANSPLANT RECIPIENTS: TWO-YEAR OUTCOMES FROM THE BENEFIT STUDY af Christian P. Larsen, Josep M. Grinyó, B Charpentier, José Osmar Medina Pestana, Nassim Kamar, Yves Vanrenterghem, Chih‐Chung Lin, G. Russo, Pushkal Garg, F. Vincenti
Udgivet 2010Artigo -
5
FTY720 versus MMF with Cyclosporine in de novo Renal Transplantation: A 1-Year, Randomized Controlled Trial in Europe and Australasia af Maurizio Salvadori, Klemens Budde, B Charpentier, Jürgen Klempnauer, Björn Nashan, Luis Pallardó, Josette Eris, Francesco Paolo Schena, Ute Eisenberger, Lionel Rostaing, Abdel Hmissi, Shreeram Aradhye
Udgivet 2006Artigo -
6
Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose—response study in elderly nursing-home residents a... af A.M. Palache, W.E.P. Beyer, M Sprenger, N. Masurel, S. De Jonge, A. Vardy, B Charpentier, J. Noury, W.C.A. van Beek, Rowie Borst, Gerard J. Ligthart, G. Keren, Eitan Rubinstein
Udgivet 1993Artigo -
7
Efficacy of Prolonged- and Immediate-release Tacrolimus in Kidney Transplantation: A Pooled Analysis of Two Large, Randomized, Controlled Trials af Bernhard K. Krämer, Luisa Albano, Bernhard Banas, B Charpentier, Lars Bäckman, Hélio Tedesco‐Silva, Frank Lehner, G. Mondragon-Ramirez, Maciej Głyda, E. Cassuto‐Viguier, Ondřej Viklický, G. Mourad, Paolo Rigotti, S Schleibner, Nassim Kamar
Udgivet 2017Artigo -
8
Daclizumab Versus Rabbit Antithymocyte Globulin in High-Risk Renal Transplants: Five-Year Follow-up of a Randomized Study af Rachel Hellemans, Marc Hazzan, D. Durand, G. Mourad, P Lang, Martin Kessler, B Charpentier, Guy Touchard, F. Berthoux, Pierre Merville, Nacéra Ouali, J.P. Squifflet, François Bayle, Karl Martin Wissing, C. Noël, Daniel Abramowicz
Udgivet 2015Artigo -
9
Three-Year Outcomes from BENEFIT, a Randomized, Active-Controlled, Parallel-Group Study in Adult Kidney Transplant Recipients af Flavio Vincenti, Christian P. Larsen, Josefina Alberú, Barbara A. Bresnahan, Valter Duro Garcı́a, J. Kothari, Philippe Lang, Eduardo Mancilla Urrea, P. Massari, G. Mondragon-Ramirez, Rafael Reyes‐Acevedo, Kim Rice, Lionel Rostaing, S. Steinberg, J. Xing, Mamta Agarwal, M. Harler, B Charpentier
Udgivet 2011Artigo -
10
Reduction of Extended-Release Tacrolimus Dose in Low-Immunological-Risk Kidney Transplant Recipients Increases Risk of Rejection and Appearance of Donor-Specific Antibodies: A Rand... af Philippe Gatault, Nassim Kamar, M. Büchler, Claudio Colosio, Dominique Bertrand, Antoine Dürrbach, Laetitia Albano, J Rivalan, Yannick Le Meur, Marie Essig, Nicolas Bouvier, Christophe Legendre, Bruno Moulin, A.E. Heng, P.-F. Weestel, Johnny Sayegh, B Charpentier, Lionel Rostaing, Éric Thervet, Yvon Lebranchu
Udgivet 2016Artigo -
11
Age-associated temporal decline in butyrate-producing bacteria plays a key pathogenic role in the onset and progression of neuropathology and memory deficits in 3×Tg-AD mice af Paula M. Chilton, Smita Ghare, B Charpentier, S Myers, Aakarsha V. Rao, Joseph F. Petrosino, Kristi L. Hoffman, John C. Greenwell, Neetu Tyagi, Jyotirmaya Behera, Yali Wang, Lucy Sloan, JingWen Zhang, Christopher Shields, Gregory E. Cooper, Leila Gobejishvili, Scott R. Whittemore, Craig J. McClain, Shirish Barve
Udgivet 2024Artigo
Søgeredskaber:
Relaterede emner
Medicine
Internal medicine
Kidney transplantation
Urology
Transplantation
Randomized controlled trial
Kidney transplant
Belatacept
Renal transplant
Gastroenterology
Immunology
Kidney
Renal function
Surgery
Tacrolimus
Antibody
Clinical endpoint
Multicenter study
Regimen
Adverse effect
Alternative medicine
Antibody response
Biochemistry
Bioinformatics
Biology
Butyrate
Ciclosporin
Cognitive decline
Creatinine
Daclizumab